International Journal of Bipolar Disorders

Papers
(The H4-Index of International Journal of Bipolar Disorders is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Postpartum mood episodes in bipolar I vs. II disorder: a retrospective observational analysis of clinical correlates51
Lipid oxidation in young patients with newly diagnosed bipolar disorder and their relatives40
Perceived cognitive loss, symptomology, and psychological well-being with bipolar disorder34
Lithium and neuroprotection: a review of molecular targets and biological effects at subtherapeutic concentrations in preclinical models of Alzheimer’s disease33
Dynamics of affect modulation in neurodevelopmental disorders (DynAMoND) – study design of a prospective cohort study29
Exploratory study of ultraviolet B (UVB) radiation and age of onset of bipolar disorder28
Characteristics of people with bipolar disorder I with and without auditory verbal hallucinations26
Association between a large change between the minimum and maximum monthly values of solar insolation and a history of suicide attempts in bipolar I disorder25
Lithium-discontinuation-induced treatment refractoriness revisited23
Is cognitive behaviour therapy applicable to individuals diagnosed with bipolar depression or suboptimal mood stabilizer treatment: a secondary analysis of a large pragmatic effectiveness trial23
Stigma in people living with bipolar disorder and their families: a systematic review21
Emotion regulation in bipolar disorder type-I: multivariate analysis of fMRI data19
The IBER study: a feasibility randomised controlled trial of imagery based emotion regulation for the treatment of anxiety in bipolar disorder19
Toxoplasma gondii IgG serointensity and cognitive function in bipolar disorder18
Advancing the prediction of factors associated with bipolar disorder risk: utilizing early recognition tools and polygenic risk scores17
Bipolar disorders in Nigeria: a mixed-methods study of patients, family caregivers, clinicians, and the community members’ perspectives17
NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior:17
0.05467700958252